Larson Financial Group’s Definium Therapeutics DFTX Stock Holding History

Larson Financial Group’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.4K	Buy	541 +6	+1%	+$148	﹤0.01%	1870
2026 Q1	$10.1K	Hold	535	–	–	﹤0.01%	2248
2025 Q4	$7.16K	Buy	+535	New	+$6.62K	﹤0.01%	2302
2025 Q3	–	Sell	-2,932	Closed	-$19K	–	3573
2025 Q2	$19K	Hold	2,932	–	–	﹤0.01%	1512
2025 Q1	$17.2K	Buy	+2,932	New	+$21K	﹤0.01%	1424
2022 Q2	–	Sell	-14	Closed	–	–	1259
2022 Q1	$0	Hold	14	–	–	﹤0.01%	1125
2021 Q4	$0	Hold	14	–	–	﹤0.01%	1140
2021 Q3	$1K	Hold	14	–	–	﹤0.01%	839
2021 Q2	$1K	Buy	+14	New	+$735	﹤0.01%	780

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Larson Financial Group's DFTX Position: Q2 2026 in Review

Larson Financial Group increased its Definium Therapeutics (DFTX) stake by 1.1% in Q2 2026, buying an estimated $148 and bringing the position to 541 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Larson Financial Group first reported a position in DFTX in Q2 2021 and has held it in 9 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Larson Financial Group held 541 shares of Definium Therapeutics worth $25.4K as of Q2 2026.
Larson Financial Group bought 6 Definium Therapeutics shares in Q2 2026, an estimated $148.
Definium Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1870 holding.
Larson Financial Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 9 quarters since.
361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.